Print

BioTime (BTX)'s Subsidiary LifeMap Sciences, Inc. Presents Update on Product Development  
4/24/2012 8:48:26 AM

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that David Warshawsky, Ph.D., CEO of BioTime’s subsidiary LifeMap Sciences, Inc. will provide and update on product development at an investor meeting in New York City today.
//-->